Grantham, Mayo, Van Otterloo & Co (GMO)’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q2
Sell
-5,600
Closed -$258K 840
2020
Q1
$258K Buy
+5,600
New +$258K ﹤0.01% 673